Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 4 months ago

Possible Interaction: Folic Acid Antagonists and Retinaldehyde

Research Papers that Mention the Interaction

Antagonists of the P2X7R prevent the ATP-induced neuronal apoptosis in the retina.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics  •  2016  |  View Paper
APN antagonists specifically inhibited angiogenesis in chorioallantoic membranes and in the retina and suppressed tumor growth.
Cancer research  •  2000  |  View Paper
P2X(7) antagonists can prevent hypoxia-induced damage in retinal neurons.
Investigative ophthalmology & visual science  •  2010  |  View Paper
RESULTS Treatment with the VE-cadherin antagonist significantly reduced retinal angiogenesis.
Archives of ophthalmology  •  2008  |  View Paper
GABA receptor antagonists produce an unexpectedly significant inhibition of native glycine receptors in retina and in alpha1 or alpha2 homomeric glycine receptors (GlyRs) expressed in HEK 293 cells.
Visual neuroscience  •  2007  |  View Paper
In vitro and in vivo studies suggest that the use of selective NMDA receptor antagonists or Ca2+ channel blockers should be useful in preventing or at least abating neuronal loss in the retina.
Vision Research  •  1997  |  View Paper
Within the retina these signals combine in an antagonistic way to form red-green and blue-yellow spectral opponent pathways.
Proceedings of the National Academy of Sciences of the United States of America  •  1996  |  View Paper
Antagonists of voltage-sensitive calcium channels, including nifedipine, methoxyverapamil (D600), Co2+, and Mg2+, were found to be effective inhibitors of the dark-dependent increase of retinal NAT activity.
Journal of neurochemistry  •  1986  |  View Paper
The potency of D2-dopamine receptor agonists and antagonists in modifying [3H]-dopamine release from rabbit retina appears to depend on the synaptic concentration of dopamine which is altered by the frequency of stimulation, and by the dopamine uptake inhibitor nomifensine.(ABSTRACT TRUNCATED AT 400 WORDS)
British journal of pharmacology  •  1986  |  View Paper
When alpha-2 antagonists are administered, they increase retinal DA metabolism of rats in the light as well as of rats in the dark.
The Journal of pharmacology and experimental therapeutics  •  1984  |  View Paper